Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing.

Journal: Nature medicine
PMID:

Abstract

Neurodegenerative disorders exhibit considerable clinical heterogeneity and are frequently misdiagnosed. This heterogeneity is often neglected and difficult to study. Therefore, innovative data-driven approaches utilizing substantial autopsy cohorts are needed to address this complexity and improve diagnosis, prognosis and fundamental research. We present clinical disease trajectories from 3,042 Netherlands Brain Bank donors, encompassing 84 neuropsychiatric signs and symptoms identified through natural language processing. This unique resource provides valuable new insights into neurodegenerative disorder symptomatology. To illustrate, we identified signs and symptoms that differed between frequently misdiagnosed disorders. In addition, we performed predictive modeling and identified clinical subtypes of various brain disorders, indicative of neural substructures being differently affected. Finally, integrating clinical diagnosis information revealed a substantial proportion of inaccurately diagnosed donors that masquerade as another disorder. The unique datasets allow researchers to study the clinical manifestation of signs and symptoms across neurodegenerative disorders, and identify associated molecular and cellular features.

Authors

  • Nienke J Mekkes
    Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. n.j.mekkes@umcg.nl.
  • Minke Groot
    The Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Eric Hoekstra
    Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Alyse de Boer
    Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Ekaterina Dagkesamanskaia
    Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Sander Bouwman
    Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Sophie M T Wehrens
    The Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Megan K Herbert
    The Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Dennis D Wever
    The Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Annemieke Rozemuller
    Department of Pathology, Amsterdam UMC loc. VUmc, Amsterdam, The Netherlands.
  • Bart J L Eggen
    Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Inge Huitinga
    The Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Inge R Holtman
    Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. i.r.holtman@umcg.nl.